These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 22048556)

  • 21. Interventions to support decision making in people considering germline genetic testing for BRCA 1/2 pathogenic and likely pathogenic variants: A scoping review.
    Pozzar RA; Seven M
    J Genet Couns; 2024 Apr; 33(2):392-401. PubMed ID: 37328917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current clinical issues and recent trends in hereditary breast and ovarian cancer in Japan-genetic testing for HBOC and risk-reducing surgery].
    Arai M; Iwase T; Takazawa Y; Takeshima N
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1333-9. PubMed ID: 25434434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-cultural adaptation and psychometric assessment of the statement format Decisional Conflict Scale for Mandarin version.
    Lu C; Mu W; Jin YH; Shi YX; Li G; Li Y; Han F; Xia T
    BMC Health Serv Res; 2019 Nov; 19(1):873. PubMed ID: 31752845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing.
    Lodder L; Frets PG; Trijsburg RW; Klijn JG; Seynaeve C; Tilanus MM; Bartels CC; Meijers-Heijboer EJ; Verhoog LC; Niermeijer MF
    Am J Med Genet A; 2003 Jun; 119A(3):266-72. PubMed ID: 12784290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer surveillance behaviors in women presenting for clinical BRCA genetic susceptibility testing.
    Loescher LJ; Lim KH; Leitner O; Ray J; D'Souza J; Armstrong CM
    Oncol Nurs Forum; 2009 Mar; 36(2):E57-67. PubMed ID: 19273395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRCA1/2 testing in hereditary breast and ovarian cancer families III: risk perception and screening.
    McInerney-Leo A; Hadley D; Kase RG; Giambarresi TR; Struewing JP; Biesecker BB
    Am J Med Genet A; 2006 Oct; 140(20):2198-206. PubMed ID: 16969872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.
    Katapodi MC; Northouse LL; Milliron KJ; Liu G; Merajver SD
    Psychooncology; 2013 Jun; 22(6):1336-43. PubMed ID: 22826208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-cultural validation of the Decisional Conflict Scale in a sample of French patients.
    Mancini J; Santin G; Chabal F; Julian-Reynier C
    Qual Life Res; 2006 Aug; 15(6):1063-8. PubMed ID: 16900286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and psychometric testing of a new instrument to measure factors influencing women's breast cancer prevention behaviors (ASSISTS).
    Khazaee-Pool M; Majlessi F; Montazeri A; Pashaei T; Gholami A; Ponnet K
    BMC Womens Health; 2016 Jul; 16():40. PubMed ID: 27444675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners.
    Mays D; DeMarco TA; Luta G; Peshkin BN; Patenaude AF; Schneider KA; Garber JE; Tercyak KP
    Health Psychol; 2014 Aug; 33(8):765-73. PubMed ID: 23795707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chinese Breast Cancer Screening Beliefs Questionnaire: development and psychometric testing with Chinese-Australian women.
    Kwok C; Fethney J; White K
    J Adv Nurs; 2010 Jan; 66(1):191-200. PubMed ID: 20423444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe.
    Marmolejo DH; Wong MYZ; Bajalica-Lagercrantz S; Tischkowitz M; Balmaña J;
    Eur J Med Genet; 2021 Dec; 64(12):104350. PubMed ID: 34606975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decisional conflict among breast cancer patients considering contralateral prophylactic mastectomy.
    Manne S; Smith B; Mitarotondo A; Frederick S; Toppmeyer D; Kirstein L
    Patient Educ Couns; 2019 May; 102(5):902-908. PubMed ID: 30553577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary breast and ovarian cancer: research on how women respond to genetic testing.
    Bingham R
    Nurs Womens Health; 2012; 16(4):319-24. PubMed ID: 22900808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term experiences with genetic consultation in people with hereditary breast and ovarian cancer.
    Eismann S; Vetter L; Keller M; Bruckner T; Golatta M; Hennings A; Domschke C; Dikow N; Sohn C; Heil J; Schott S
    Arch Gynecol Obstet; 2016 Nov; 294(5):1011-1018. PubMed ID: 27282618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A descriptive study of BRCA1 testing and reactions to disclosure of test results.
    Lynch HT; Lemon SJ; Durham C; Tinley ST; Connolly C; Lynch JF; Surdam J; Orinion E; Slominski-Caster S; Watson P; Lerman C; Tonin P; Lenoir G; Serova O; Narod S
    Cancer; 1997 Jun; 79(11):2219-28. PubMed ID: 9179070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
    Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
    Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.